Loading patent…
AssigneesJichi Medical University, Otsuka Pharmaceutical Factory, Inc.
InventorsEiji Kobayashi, Tamaki Wada, Yasutaka Fujita, Norihiro Yoshinaga, Masako Doi, Yasuhiro Fujimoto, Takumi Teratani
Estimating the term…
The present invention provides a mammalian stem cell suspension containing mammalian stem cells and at least one polysaccharide such as trehalose, and the like; a mammalian stem cell aggregation inhibitor containing polysaccharide such as trehalose, and the like; a method of suppressing aggregation of mammalian stem cells, containing suspending the mammalian stem cells in an aqueous physiological solution containing polysaccharide; an inhibitor of a decrease in the survival rate of mammalian stem cells containing polysaccharide such as trehalose and the like; a method of suppressing a decrease in the survival rate of mammalian stem cells, containing suspending the mammalian stem cells in an aqueous physiological solution containing polysaccharides, and the like.
1-10. (canceled)
A mammalian stem cell aggregation inhibitor comprising at least one polysaccharide selected from the group consisting of trehalose, hydroxyethylstarch and dextran.
A method of suppressing aggregation of mammalian stem cells, comprising suspending the mammalian stem cells in an aqueous physiological solution containing at least one polysaccharide selected from the group consisting of trehalose, hydroxyethylstarch and dextran.
22-34. (canceled)
Dependencies are inferred from the claim text.